1 min left

0% read

Genesis Molecular AI

Infrastructure

Software

Foundation

Burlingame, California, USA

Founded 2019

144

Genesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development.

Genesis Molecular AI

Headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York, Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space) to accelerate and optimize small molecule drug discovery.

The GEMS platform integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through cycles of AI-enabled discovery and optimization.

We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI platform collaborations across a range of therapeutic areas including Gilead (2024) and Incyte (2025).

Genesis has raised over $300M in funding from top AI, technology, and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. To learn more about Genesis Molecular AI or current employment opportunities, please visit our website.

Frequently Asked Questions About Genesis Molecular AI

Genesis Molecular AI is an infrastructure company. Genesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development.

Genesis Molecular AI has been operating since 2019. You can verify their legitimacy through their official website and social media presence.

Genesis Molecular AI operates in the infrastructure sector of the cryptocurrency industry. Compare Genesis Molecular AI with other infrastructure companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Genesis Molecular AI, research their track record (operating since 2019), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Genesis Molecular AI is based in Burlingame, California, USA, has been operating since 2019. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Genesis Molecular AI is based in Burlingame, California, USA, North America, with offices in Burlingame, California, USA, San Diego, California, USA.

Genesis Molecular AI was founded in 2019. The company currently has 144 employees.

Genesis Molecular AI Details

Genesis Molecular AI Offices (6)

Genesis Molecular AI Tags

More About Genesis Molecular AI

Work Model Details

Employees work from physical offices.

Latest from Academy

Trading Analysis

Four Catalysts Could Push PAX Gold Past $5,200 by 2027

PAXG is not a stablecoin. It's a tokenized commodity that has all the upside of gold and is by no means topped out near $4,556 as of April 2. Any realistic price target model for where Pax Gold price will be in 12-18 months needs to account for 4 unique catalysts that have not yet fully played out. If all 4 catalysts begin to kick in, $5,200 wouldn't just be possible, it'd be expected.

Crypto News Navigator17h ago

8m read

Blockchain

Why Circle and Paxos Both Chose Aleo for Stablecoins

By 2025, stablecoins will have been traded $33 trillion. Less than 1% of businesses issue employee salaries in cryptocurrency. The biggest blocker is that sending salary payments, vendor invoices, and treasury balances on public blockchains exposes that information to anyone who pulls it up on a block explorer. Privacy-focused Layer 1 Aleo was made for enterprises trying to solve this problem.

Mia HallandApr 9, 2026

10m read

Trading Analysis

Bounce Token Price Just Hit a Critical Inflection Point

AUCTION is trading at $4.74, only 50% above its historic low of $3.16 and 93.3% below its all-time high of $70.44. The proximity to the bottom isn't coincidental,it's a structural signal. While 24-hour trading volume increased 33.9% to $6.07 million, the token was flashing patterns worthy of a forensic breakdown.

Archie DuttonApr 9, 2026

8m read